Application of the Belle.AI Dermatological Image Reference System for Patient Diagnosis in an Active Clinical Setting

Part of paid clinical trials in The Bronx, New York.

Sponsor
BelleTorus Corporation
Study ID
NCT06724627
Status
Recruiting

Conditions

  • Dermatology
  • Dermatology/Skin - Other
  • Skin Condition

Eligibility Criteria

Sex
ALL
Age
N/A - N/A
Healthy Volunteers
Not accepted

Interventions

  • Dermatology/Skin - Other — DIAGNOSTIC_TEST
    Belle AI for skin image assessment.

Study Details

The goal of this research study is to test a new, investigational tool that uses artificial intelligence (AI) to help primary care providers assess skin conditions. This tool is an AI-powered dermatology image reference app that works with a smartphone. For clarity, the AI makes no diagnoses; it provides reference images. Primary care providers then use their own medical judgement and training to make the diagnosis. The sponsor aims to compare the diagnoses made by primary care providers (such as doctors, nurse practitioners, and physician assistants) with the support of the AI tool compared to a panel of dermatologists, who are setting the gold standard. By doing so, the sponsor can determine the value of the AI tool for primary care providers and understand how it might be used alongside traditional clinical care. This AI capability complies with FDA regulatory guidelines and is not considered a medical device, similar to a Google image search, which returns similar looking images for reference purposes. For intervention, they healthcare providers use their own training and clinical judgement to make the diagnosis, and not the AI.

Key Dates

Start date
Sep 16, 2024
Status verified
Dec 2024
Primary completion
Mar 30, 2025
Completion
Jun 30, 2025

Study Design

Enrollment
263 participants (estimated)
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC

Arms

  • Other: Standard of care
    Standard of care

Primary Outcome Measure

Accuracy of Belle AI Image References [ Time Frame: Through study completion, an average of 14 days ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Urban Health Plan Inc.The BronxNew York07059
Franco Barsanti, PharmD
347-446-0227
Carina Puello, BSN
917-251-0223
Samuel DeLeon, MD (PRINCIPAL_INVESTIGATOR)
Acklema Mohammad, MD (PRINCIPAL_INVESTIGATOR)

Find similar trials in The Bronx, NY